With HIV diagnosis rates at approximately 90%, HIV experts in Germany united through a Gilead initiative to bridge the final gap. Watch the full video: https://gilead.inc/3We4oh5 #AIDS2024 | #PutPeopleFirst
Gilead Sciences
Ricerca biotecnologica
Foster City, CA 630.218 follower
Creating Possible
Chi siamo
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines
- Sito Web
-
http://www.gilead.com
Link esterno per Gilead Sciences
- Settore
- Ricerca biotecnologica
- Dimensioni dell’azienda
- Oltre 10.001 dipendenti
- Sede principale
- Foster City, CA
- Tipo
- Società quotata
- Data di fondazione
- 1987
Località
Dipendenti presso Gilead Sciences
Aggiornamenti
-
We're committed to transformational collaborations at the global, national and local levels that aim to help address the diverse health needs and preferences of those affected by #HIV. Jared Baeten, SVP, Clinical Development, Virology, sat down with New Scientist to talk about Gilead’s commitment to person-centric innovation that extends beyond the lab. https://gilead.inc/4f5UOp4 #AIDS2024 | #PutPeopleFirst
Hear about the critical intersection of scientific innovation and health equity
-
For the fifth year, we’re on the Seramount 100 Best Companies list for our inclusive workplace and culture. Investing in our people can inspire a healthier and happier workforce that drives collaboration and impact. “Our people are our greatest asset and prioritizing their wellbeing is a cornerstone of Gilead’s culture. That’s why we continue to offer comprehensive benefits, create a supportive work environment and advocate for a healthy work-life balance,” says Jyoti Mehra, Executive Vice President, Human Resources. #Seramount100Best
-
#GileadNews: We’ll share data from our research and development programs and collaborations at #AIDS2024, underscoring our commitment to a person-centered approach to help advance progress toward ending the HIV epidemic. https://gilead.inc/3W4HGrE
-
At The Hollywood Reporter Social Impact Summit last week, a panel discussion focused on the importance of using public platforms for good and the ways community organizations, advocates, celebrities and business leaders can work together to help end the HIV epidemic. “By leveraging their large platforms to amplify HIV awareness and education, public figures play an essential role in reducing stigma and engaging their followers,” said panelist Carmen Villar, VP, ESG and Corporate Citizenship at Gilead.
-
Last month marked Gilead's Month of Service, an annual tradition where employees step away from their desks and work alongside local organizations to make an impact in their communities. Our service activities included gardening and landscaping, assembling backpacks and STEM supply kits for children, building homes, providing art and science classes to children living with HIV and viral hepatitis and packing meals at food banks. By actively engaging with communities in need, we get closer to our vision of a healthier world for all people.
-
Gilead and Kite Pharma have been recognized by the Association of Energy Engineers and named recipients of the 2024 International and Regional Awards for outstanding contributions to the field of energy efficiency and sustainability. Our passion for creating a better, healthier world drives us to be responsible corporate citizens.
-
Last week, world leaders, CEOs, entrepreneurs and change agents came together at the 2024 Global Black Economic Forum’s Business Summit at the Essence Communications Inc. Festival of Culture - a platform where leaders could collaborate and connect. During the summit, Daniel O'Day, Chairman and CEO, Deborah Telman, EVP, Corporate Affairs and General Counsel, Anthony Welters, Lead Independent Director and Kevin E Lofton, Former Lead Independent Director, discussed how Gilead’s leadership diversity helps drive scientific innovation and impacts communities with the greatest unmet needs.
-
-
During #PrideMonth, Gilead and Kite Pharma employees, families and friends proudly participated in the San Francisco Pride and WeHo Pride parades to celebrate the LGBTQ+ community, embodying our theme of “live, love, liberate” -- an anthem of equality and inclusion for all.
-
-
#GileadNews: Yesterday, we shared results of a study on an investigational medication for #HIV prevention. Now, guided by our two decades of innovation and leadership in global access to medicines, we’re announcing our approach to ensure access to that medication, if approved, in countries that represent the highest HIV burden in the world. https://gilead.inc/3VTChF5
-
Pagine affiliate
Pagine simili
Sfoglia le offerte di lavoro
Azioni
GILD
NASDAQ
Ritardo di 20 minuti
72,56 USD
-0,95 (-1,292%)
- Apertura
- 73,51
- Minimo
- 71,96
- Massimo
- 73,74
Dati da Refinitiv
Vedi altre informazioni suRaccolta fondi
Gilead Sciences
4 round in totale
![]()
Abingworth
Vedi altre informazioni su Crunchbase
Ultimo round
Capitale post-IPO
Link al sito Crunchbase esterno per l’ultimo round di raccolta fondi
210.000.000,00 USD
Investitori